By contrast, a recent study has shown that, in mice, administration of Gal-3 is associated with insulin resistance, and that Gal-3 inhibition, pharmacologically or genetically, causes glucose intolerance in HFD animals for 8 weeks (Li et al., 2016). This evidence concerns the gene LGALS3 and Glucose intolerance.